Submitted:
17 July 2026
Posted:
20 July 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Methodology
3. Results and Discussion
3.1. Caffeine Location
3.2. Cluster Analysis
3.3. Caffeine Orientation
3.4. Nematic Correlation Function
3.5. Effect of Caffeine on the Membrane Bilayer
3.5.1. Surface Area and Bilayer Thickness
3.5.2. Deuterium Order Parameter

3.6. Effect of Initial Caffeine Placement
3.7. System Size Effect and Reproducibility
4. Conclusions
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| DPPC | 1,2-dipalmitoyl-sn-glycero-3-phosphocholine |
| MD | molecular dynamics |
| CNS | central nervous system; |
| HCC | Hepatocellular carcinoma |
| CKD | chronic kidney disease |
| BLF | glycoprotein bovine lactoferrin |
| DODAB | dioctadecyldimethylammonium bromide |
| QENS | Quasielastic neutron scattering; |
| ADME | absorption, distribution, metabolism, and excretion |
| POPG | palmitoyl-2-oleoylphosphatidylglycerol |
| DOPC | 1,2-dioleoyl-sn-glycero-3-phosphocholine |
| PMF | potential of mean force |
| POPC | 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine |
| ATB | Automated Force Field Topology Builder |
| VMD | Visual Molecular Dynamics |
| PME | particle-mesh Ewald |
| PC | phosphatidylcholine |
| C.o.M. | center-of-mass |
| HG-AC | headgroup–acyl chain |
| DFT | DFT, Density Functional Theory |
| APL | Area per lipid |
| SCD | Deuterium order parameter |
References
- Martinotti, C.; Ruiz-Perez, L.; Deplazes, E.; Mancera, R. L. Molecular Dynamics Simulation of Small Molecules Interacting with Biological Membranes. In Wiley-VCH Verlag; 17 Jul 2020. [Google Scholar] [CrossRef] [PubMed]
- Di Meo, F.; et al. , In silico pharmacology: Drug membrane partitioning and crossing. Pharmacol. Res. 2016, vol. 111, 471–486. [Google Scholar] [CrossRef] [PubMed]
- Kopec̈, W.; Telenius, J.; Khandelia, H. Molecular dynamics simulations of the interactions of medicinal plant extracts and drugs with lipid bilayer membranes. FEBS J. 2013, vol. 280(no. 12), 2785–2805. [Google Scholar] [CrossRef] [PubMed]
- Smith. Caffeine; 2005. [Google Scholar] [CrossRef]
- Romero-Martínez, S.; et al. , Possible Beneficial Actions of Caffeine in SARS-CoV-2. Int. J. Mol. Sci. 2021, vol. 22(no. 11). [Google Scholar] [CrossRef] [PubMed]
- Bawornruttanaboonya, K.; Chindapan, N.; Devahastin, S. Numerical Investigation of Conventional and Ultrasound-Assisted Aqueous Extraction of Caffeine from Whole Green Robusta Coffee Beans: Extraction Enhancement via Changing of Extraction Water. Foods 2025, vol. 14(no. 11), 1956. [Google Scholar] [CrossRef]
- Di Pietrantonio, D.; Pace Palitti, V.; Cichelli, A.; Tacconelli, S. Protective Effect of Caffeine and Chlorogenic Acids of Coffee in Liver Disease. Foods 2024, Vol. 13, Page 2280, vol. 13(no. 14), 2280. [Google Scholar] [CrossRef] [PubMed]
- Hsu, C. W.; Wang, C. S.; Chiu, T. H. Caffeine and a selective adenosine A2A receptor antagonist induce sensitization and cross-sensitization behavior associated with increased striatal dopamine in mice. J. Biomed. Sci. 2010, vol. 17(no. 1), 4. [Google Scholar] [CrossRef] [PubMed]
- Do, H. N.; Akhter, S.; Miao, Y. “Pathways and Mechanism of Caffeine Binding to Human Adenosine A2A Receptor,” Front. Mol. Biosci. 2021, vol. 8. [Google Scholar] [CrossRef] [PubMed]
- López-Cruz, L.; Salamone, J. D.; Correa, M. Caffeine and selective adenosine receptor antagonists as new therapeutic tools for the motivational symptoms of depression. Front. Pharmacol. 2018, vol. 9, no. JUN, 353416. [Google Scholar] [CrossRef]
- Ruggiero, M.; Calvello, R.; Porro, C.; Messina, G.; Cianciulli, A.; Panaro, M. A. Neurodegenerative Diseases: Can Caffeine Be a Powerful Ally to Weaken Neuroinflammation? 2022, MDPI. [Google Scholar] [CrossRef] [PubMed]
- Gaascht, F.; Dicato, M.; Diederich, M. Coffee provides a natural multitarget pharmacopeia against the hallmarks of cancer. Genes Nutr. 2015, vol. 10(no. 6), 1–17. [Google Scholar] [CrossRef] [PubMed]
- Elzupir, O. Caffeine and caffeine-containing pharmaceuticals as promising inhibitors for 3-chymotrypsin-like protease of SARS-CoV-2. J. Biomol. Struct. Dyn. 2022, vol. 40(no. 5), 2113–2120. [Google Scholar] [CrossRef] [PubMed]
- Saraiva, S. M.; Jacinto, T. A.; Gonçalves, A. C.; Gaspar, D.; Silva, L. R. Overview of Caffeine Effects on Human Health and Emerging Delivery Strategies. Pharm. 2023 2023, Vol. 16, Page 1067, vol. 16(no. 8), 1067. [Google Scholar] [CrossRef] [PubMed]
- Yuan, S.; Larsson, S. C. Coffee and Caffeine Consumption and Risk of Kidney Stones: A Mendelian Randomization Study. Am. J. Kidney Dis. 2022, vol. 79(no. 1), 9–14.e1. [Google Scholar] [CrossRef] [PubMed]
- Kanlaya, R.; Subkod, C.; Nanthawuttiphan, S.; Thongboonkerd, V. Caffeine causes cell cycle arrest at G0/G1 and increases of ubiquitinated proteins, ATP and mitochondrial membrane potential in renal cells. Comput. Struct. Biotechnol. J. 2023, vol. 21, 4552–4566. [Google Scholar] [CrossRef] [PubMed]
- Srithongkul, T.; Ungprasert, P. Coffee Consumption is Associated with a Decreased Risk of Incident Chronic Kidney Disease: A Systematic Review and Meta-analysis of Cohort Studies. Eur. J. Intern. Med. 2020, vol. 77, 111–116. [Google Scholar] [CrossRef] [PubMed]
- Heath, R. D.; Brahmbhatt, M.; Tahan, A. C.; Ibdah, J. A.; Tahan, V. Coffee: The magical bean for liver diseases. World J. Hepatol. 2017, vol. 9(no. 15), 689–696. [Google Scholar] [CrossRef] [PubMed]
- Li, Z.; et al. Molecular insight into binding behavior of caffeine with lactoferrin: Spectroscopic, molecular docking, and simulation study. J. Dairy Sci. 2023, vol. 106(no. 12), 8249–8261. [Google Scholar] [CrossRef] [PubMed]
- Alao, J. P.; Kumar, J.; Stamataki, D.; Rallis, C. Dissecting the cell cycle regulation, DNA damage sensitivity and lifespan effects of caffeine in fission yeast. Microb. Cell 2025, vol. 12(no. 1), 141–156. [Google Scholar] [CrossRef] [PubMed]
- Lin, Z.; Wei, J.; Hu, Y.; Pi, D.; Jiang, M.; Lang, T. Caffeine Synthesis and Its Mechanism and Application by Microbial Degradation, A Review. Foods 2023 2023, Vol. 12, Page 2721, vol. 12(no. 14), 2721. [Google Scholar] [CrossRef] [PubMed]
- Rodak, K.; Kokot, I.; Kratz, E. M. Caffeine as a factor influencing the functioning of the human body—friend or foe? Nutrients 2021, vol. 13(no. 9). [Google Scholar] [CrossRef] [PubMed]
- Musgrave, F.; Farrington, R. L.; Hoban, C.; Byard, R. W. Caffeine toxicity in forensic practice: possible effects and under-appreciated sources. Forensic Sci. Med. Pathol. 2016, vol. 12(no. 3), 299–303. [Google Scholar] [CrossRef] [PubMed]
- Yan, Y.; et al. Molecular view of the interactions between the amphiphilic drug propranolol hydrochloride and model lipid membranes. J. Colloid Interface Sci. 2026, vol. 708, 139814. [Google Scholar] [CrossRef] [PubMed]
- Sharma, V. K.; Srinivasan, H.; García Sakai, V.; Mitra, S. Caffeine modulates the dynamics of DODAB membranes: Role of the physical state of the bilayer. arXiv Soft Condens. Matter 2020, vol. 128(no. 15). [Google Scholar] [CrossRef]
- Sharifian Gh, M. Recent Experimental Developments in Studying Passive Membrane Transport of Drug Molecules. Mol. Pharm. 2021, vol. 18(no. 6), 2122–2141. [Google Scholar] [CrossRef] [PubMed]
- Alves, C.; Ribeiro, D.; Nunes, C.; Reis, S. Biophysics in cancer: The relevance of drug-membrane interaction studies. Biochim. Et. Biophys. Acta (BBA) -Biomembr. 2016, vol. 1858(no. 9), 2231–2244. [Google Scholar] [CrossRef] [PubMed]
- Li, H.; Zhao, T.; Sun, Z. Analytical techniques and methods for study of drug-lipid membrane interactions. Rev. Anal. Chem. 2018, vol. 37(no. 1). [Google Scholar] [CrossRef]
- Xu, Y.; Yushmanov, V. E.; Tang, P. NMR Studies of Drug Interaction with Membranes and Membrane-Associated Proteins. Biosci. Rep. 2002, vol. 22(no. 2), 175–196. [Google Scholar] [CrossRef] [PubMed]
- Seddon, M.; et al. Drug interactions with lipid membranes. 2009, vol. 38(no. 9). [Google Scholar] [CrossRef] [PubMed]
- Peetla; Stine, A.; Labhasetwar, V. reviews Biophysical Interactions with Model Lipid Membranes : Applications in Drug Discovery and Drug Delivery 2009, no. 4, 8053–8058.
- Paloncýová, M.; Berka, K.; Otyepka, M. Molecular insight into affinities of drugs and their metabolites to lipid bilayers. J. Phys. Chem. B 2013, vol. 117(no. 8), 2403–2410. [Google Scholar] [CrossRef] [PubMed]
- Paloncýová, M.; Devane, R.; Murch, B.; Berka, K.; Otyepka, M. Amphiphilic drug-like molecules accumulate in a membrane below the head group region. J. Phys. Chem. B 2014, vol. 118(no. 4), 1030–1039. [Google Scholar] [CrossRef] [PubMed]
- Khondker, et al. Partitioning of caffeine in lipid bilayers reduces membrane fluidity and increases membrane thickness. Phys. Chem. Chem. Phys. 2017, vol. 19(no. 10), 7101–7111. [Google Scholar] [CrossRef] [PubMed]
- Tavagnacco, L.; Corucci, G.; Gerelli, Y. Interaction of Caffeine with Model Lipid Membranes. J. Phys. Chem. B 2021, vol. 125(no. 36), 10174–10181. [Google Scholar] [CrossRef]
- Tavagnacco, L.; Schnupf, U.; Mason, P. E.; Saboungi, M. L.; Cesàro, A.; Brady, J. W. Molecular Dynamics Simulation Studies of Caffeine Aggregation in Aqueous Solution. J. Phys. Chem. B 2011, vol. 115(no. 37), 10957. [Google Scholar] [CrossRef] [PubMed]
- Tavagnacco, L.; Di Fonzo, S.; D’Amico, F.; Masciovecchio, C.; Brady, J. W.; Cesàro, A. Stacking of purines in water: the role of dipolar interactions in caffeine. Phys. Chem. Chem. Phys. 2016, vol. 18(no. 19), 13478–13486. [Google Scholar] [CrossRef] [PubMed]
- Tavagnacco, L.; Gerelli, Y.; Cesàro, A.; Brady, J. W. Stacking and Branching in Self-Aggregation of Caffeine in Aqueous Solution: From the Supramolecular to Atomic Scale Clustering. J. Phys. Chem. B 2016, vol. 120(no. 37), 9987–9996. [Google Scholar] [CrossRef] [PubMed]
- Das, S.; Karayiannis, N. C.; Roy, S. DPPC Membrane Under Lateral Compression and Stretching to Extreme Limits: Phase Transitions and Rupture. Membranes . 2025, vol. 15(no. 6), 161. [Google Scholar] [CrossRef]
- Kitjanon; Nisoh, N.; Phongphanphanee, S.; Chattham, N.; Karttunen, M.; Wong-ekkabut, J. Dispersion of Hydrophilic Nanoparticles in Natural Rubber with Phospholipids. Polymers . 2024, vol. 16(no. 20). [Google Scholar] [CrossRef] [PubMed]
- Guo, X. Y.; Peschel, C.; Watermann, T.; von Rudorff, G. F.; Sebastiani, D. Cluster formation of polyphilic molecules solvated in a DPPC bilayer. Polymers . 2017, vol. 9(no. 10). [Google Scholar] [CrossRef] [PubMed]
- Przybyłek, M.; et al. , Molecular Insights into the Interactions Between Human Serum Albumin and Phospholipid Membranes. Appl. Sci. 2024, vol. 14(no. 24). [Google Scholar] [CrossRef]
- Yin, Q.; Shi, X.; Ding, H.; Dai, X.; Wan, G.; Qiao, Y. Interactions of borneol with DPPC phospholipid membranes: A molecular dynamics simulation study. Int. J. Mol. Sci. 2014, vol. 15(no. 11), 20365–20381. [Google Scholar] [CrossRef] [PubMed]
- Neupane, S.; Cordoyiannis, G.; Renner, F. U.; Losada-Pérez, P. Real-Time monitoring of interactions between solid-supported lipid vesicle layers and shortand medium-chain length alcohols: Ethanol and 1-pentanol. Biomimetics 2019, vol. 4(no. 1). [Google Scholar] [CrossRef] [PubMed]
- Dai, Y.; Xie, Z.; Liang, L. Pore Formation Mechanism of A-Beta Peptide on the Fluid Membrane: A Combined Coarse-Grained and All-Atomic Model. Molecules 2022, vol. 27(no. 12). [Google Scholar] [CrossRef] [PubMed]
- Van Der Spoel, D.; Lindahl, E.; Hess, B.; Groenhof, G.; Mark, A. E.; Berendsen, H. J. C. GROMACS: Fast, flexible, and free; Dec 2005. [Google Scholar] [CrossRef] [PubMed]
- Berger; Edholm, O.; Jähnig, F. Molecular dynamics simulations of a fluid bilayer of dipalmitoylphosphatidylcholine at full hydration, constant pressure, and constant temperature. Biophys. J. vol. 72(no. 5), 2002–2013, 1997. [CrossRef] [PubMed]
- Kasparyan, G.; Hub, J. S. Molecular Simulations Reveal the Free Energy Landscape and Transition State of Membrane Electroporation. Phys. Rev. Lett. 2024, vol. 132(no. 14). [Google Scholar] [CrossRef] [PubMed]
- Filipe, H. A. L.; Loura, L. M. S.; Moreno, M. J. Permeation of a Homologous Series of NBD-Labeled Fatty Amines through Lipid Bilayers: A Molecular Dynamics Study. Membranes . 2023, vol. 13(no. 6). [Google Scholar] [CrossRef] [PubMed]
- Rossos, G.; Hadjikakou, S. K.; Kourkoumelis, N. Molecular dynamics simulation of 2-benzimidazolyl-urea with dppc lipid membrane and comparison with a copper(Ii) complex derivative. Membranes . 2021, vol. 11(no. 10). [Google Scholar] [CrossRef] [PubMed]
- Capelli, R.; Gardin, A.; Empereur-Mot, C.; Doni, G.; Pavan, G. M. A Data-Driven Dimensionality Reduction Approach to Compare and Classify Lipid Force Fields. J. Phys. Chem. B 2021, vol. 125(no. 28), 7785–7796. [Google Scholar] [CrossRef] [PubMed]
- Cordomí; Caltabiano, G.; Pardo, L. Membrane protein simulations using AMBER force field and Berger lipid parameters. J. Chem. Theory Comput. 2012, vol. 8(no. 3), 948–958. [Google Scholar] [CrossRef] [PubMed]
- Zeng, S.; Chen, J.; Wang, X.; Zhou, G.; Chen, L.; Dai, C. Selective Transport through the Ultrashort Carbon Nanotubes Embedded in Lipid Bilayers. J. Phys. Chem. C 2018, vol. 122(no. 48), 27681–27688. [Google Scholar] [CrossRef]
- Chen, et al. Encapsulation and Release of Drug Molecule Pregabalin Based on Ultrashort Single-Walled Carbon Nanotubes. J. Phys. Chem. C 2019, vol. 123(no. 14), 9567–9574. [Google Scholar] [CrossRef]
- Chen, J.; Zhou, G.; Chen, L.; Wang, Y.; Wang, X.; Zeng, S. Interaction of Graphene and its Oxide with Lipid Membrane: A Molecular Dynamics Simulation Study. J. Phys. Chem. C 2016, vol. 120(no. 11), 6225–6231. [Google Scholar] [CrossRef]
- Polvat, T.; et al. The potential mechanism of methamphetamine-induced mitochondrial dysfunction and cell degeneration via direct permeation across mitochondrial membranes: The study on molecular dynamics simulations and in vitro model. Food Chem. Toxicol. 2025, vol. 206. [Google Scholar] [CrossRef] [PubMed]
- Schmid, N.; et al. Definition and testing of the GROMOS force-field versions 54A7 and 54B7. Eur. Biophys. J. 2011, vol. 40(no. 7), 843–856. [Google Scholar] [CrossRef] [PubMed]
- Pedersen, B.; et al. The Martini 3 Lipidome: Expanded and Refined Parameters Improve Lipid Phase Behavior. ACS Cent. Sci. 2025, vol. 11(no. 9), 1598–1610. [Google Scholar] [CrossRef] [PubMed]
- Marrink, S. J.; Risselada, H. J.; Yefimov, S.; Tieleman, D. P.; De Vries, A. H. The MARTINI Force Field: Coarse Grained Model for Biomolecular Simulations. J. Phys. Chem. B 2007, vol. 111(no. 27), 7812–7824. [Google Scholar] [CrossRef] [PubMed]
- Shinoda, W.; Devane, R.; Klein, M. L. Multi-property fitting and parameterization of a coarse grained model for aqueous surfactants. Mol. Simul. 2007, vol. 33(no. 1–2), 27–36. [Google Scholar] [CrossRef]
- Wu, J.; Mukherji, D. Comparison of all atom and united atom models for thermal transport calculations of amorphous polyethylene. Comput. Mater. Sci. 2022, vol. 211, 111539. [Google Scholar] [CrossRef]
- Oliveira, P.; Gonçalves, Y. M. H.; Ol Gheta, S. K.; Rieder, S. R.; Horta, B. A. C.; Hünenberger, P. H. Comparison of the United- and All-Atom Representations of (Halo)alkanes Based on Two Condensed-Phase Force Fields Optimized against the Same Experimental Data Set. J. Chem. Theory Comput. 2022, vol. 18(no. 11), 6757–6778. [Google Scholar] [CrossRef] [PubMed]
- Harrison, J. A.; Schall, J. D.; Maskey, S.; Mikulski, P. T.; Knippenberg, M. T.; Morrow, B. H. Review of force fields and intermolecular potentials used in atomistic computational materials research. Appl. Phys. Rev. 2018, vol. 5(no. 3). [Google Scholar] [CrossRef]
- Humphrey, W.; Dalke, A.; Schulten, K. VMD - Visual Molecular Dynamics. In J. Molec. Graphics; 1996. [Google Scholar]
- Marrink, S. J.; Berger, O.; Tieleman, P.; Jähnig, F. Adhesion forces of lipids in a phospholipid membrane studied by molecular dynamics simulations. Biophys. J. 1998, vol. 74 no. 2 Pt 1, 931. [Google Scholar] [CrossRef] [PubMed]
- Nagle, J. F.; Tristram-Nagle, S. Structure of lipid bilayers. Biochim. Biophys. Acta 2000, vol. 1469(no. 3), 159. [Google Scholar] [CrossRef] [PubMed]
- Berendsen, H. J. C.; Postma, J. P. M.; van Gunsteren, W. F.; Hermans, J. Interaction Models for Water in Relation to Protein Hydration; 1981; pp. 331–342. [Google Scholar] [CrossRef]
- Hess, B.; Bekker, H.; Berendsen, H. J. C.; Fraaije, J. G. E. M. LINCS: A linear constraint solver for molecular simulations. J. Comput. Chem. 1997, vol. 18(no. 12), 1463–1472. [Google Scholar] [CrossRef]
- Darden, T.; York, D.; Pedersen, L. Particle mesh Ewald: An N·log(N) method for Ewald sums in large systems. J. Chem. Phys. 1993, vol. 98(no. 12), 10089–10092. [Google Scholar] [CrossRef]
- Nosé, S. A unified formulation of the constant temperature molecular dynamics methods. J. Chem. Phys. 1984, vol. 81(no. 1), 511–519. [Google Scholar] [CrossRef]
- Nosé, S. A molecular dynamics method for simulations in the canonical ensemble. Mol. Phys. 1984, vol. 52(no. 2), 255–268. [Google Scholar] [CrossRef]
- Hoover, W. G. Canonical dynamics: Equilibrium phase-space distributions. Phys. Rev. A (Coll. Park) . 1985, vol. 31(no. 3), 1695. [Google Scholar] [CrossRef] [PubMed]
- Parrinello; Rahman, A. Polymorphic transitions in single crystals: A new molecular dynamics method. J. Appl. Phys. 1981, vol. 52(no. 12), 7182–7190. [Google Scholar] [CrossRef]
- Nosé, S.; Klein, M. L. Constant pressure molecular dynamics for molecular systems. Mol. Phys. 1983, vol. 50(no. 5), 1055–1076. [Google Scholar] [CrossRef]
- Malde, K.; et al. An Automated force field Topology Builder (ATB) and repository: Version 1.0. J. Chem. Theory Comput. 2011, vol. 7(no. 12), 4026–4037. [Google Scholar] [CrossRef] [PubMed]
- Koziara, K. B.; Stroet, M.; Malde, A. K.; Mark, A. E. Testing and validation of the Automated Topology Builder (ATB) version 2.0: Prediction of hydration free enthalpies. J. Comput. Aided. Mol. Des. 2014, vol. 28(no. 3), 221–233. [Google Scholar] [CrossRef] [PubMed]
- Stroet, M.; Caron, B.; Visscher, K. M.; Geerke, D. P.; Malde, A. K.; Mark, A. E. Automated topology builder version 3.0: prediction of solvation free enthalpies in water and hexane. J. Chem. Theory Comput. 2018, vol. 14(no. 11), 5834–5845. [Google Scholar] [CrossRef] [PubMed]
- Herranz, M.; Pedrosa, C.; Martínez-Fernández, D.; Foteinopoulou, K.; Karayiannis, N. C.; Laso, M. Fine-tuning of colloidal polymer crystals by molecular simulation. Phys. Rev. E 2023, vol. 107(no. 6), 064605. [Google Scholar] [CrossRef] [PubMed]
- Senthilnithy, R.; Weerasingha, M. S. S.; Dissanayake, D. P. Interaction of caffeine dimers with water molecules. Comput. Theor. Chem. 2014, vol. 1028, 60–64. [Google Scholar] [CrossRef]
- Vraneš, M.; Borović, T. T.; Drid, P.; Trivić, T.; Tomaš, R.; Janković, N. Influence of Sodium Salicylate on Self-Aggregation and Caffeine Solubility in Water—A New Hypothesis from Experimental and Computational Data. Pharmaceutics 2022, vol. 14(no. 11), 2304. [Google Scholar] [CrossRef]
- Gutierrez, M. P. S.; Jimenez, E. G.; Deriabina, A.; Perez, J. C. S.; Poltev, V. Reproduction of experimental data for stacked caffeine dimers using various computational methods. Sci. Rep. 2024, vol. 14(no. 1). [Google Scholar] [CrossRef] [PubMed]
- Wilson, M. R. Determination of order parameters in realistic atom-based models of liquid crystal systems. J. Mol. Liq. 1996, vol. 68(no. 1), 23–31. [Google Scholar] [CrossRef]
- Roy, S.; Chen, Y. L. Rich phase transitions in strongly confined polymer-nanoparticle mixtures: Nematic ordering, crystallization, and liquid-liquid phase separation. J. Chem. Phys. 2021, vol. 154(no. 2). [Google Scholar] [CrossRef]
- Sharma, B.; Paul, S. Effects of dilute aqueous NaCl solution on caffeine aggregation. J. Chem. Phys. 2013, vol. 139(no. 19). [Google Scholar] [CrossRef] [PubMed]
- Sun, D.; et al. Assessing the Perturbing Effects of Drugs on Lipid Bilayers Using Gramicidin Channel-Based in Silico and in Vitro Assays. J. Med. Chem. 2020, vol. 63(no. 20), 11809–11818. [Google Scholar] [CrossRef] [PubMed]
- Peyear, T. A.; Andersen, O. S. Screening for bilayer-active and likely cytotoxic molecules reveals bilayer-mediated regulation of cell function. J. General. Physiol. 2023, vol. 155(no. 4). [Google Scholar] [CrossRef] [PubMed]
- Grage, S. L.; Afonin, S.; Kara, S.; Buth, G.; Ulrich, A. S. Membrane thinning and thickening induced by membrane-active amphipathic peptides. Front. Cell Dev. Biol. 2016, vol. 4, no. JUN. [Google Scholar] [CrossRef] [PubMed]
- Shinoda, W.; Okazaki, S. A Voronoi analysis of lipid area fluctuation in a bilayer. J. Chem. Phys. 1998, vol. 109(no. 4), 1517–1521. [Google Scholar] [CrossRef]
- Michaud-Agrawal; Denning, E. J.; Woolf, T. B.; Beckstein, O. MDAnalysis: a toolkit for the analysis of molecular dynamics simulations. J. Comput. Chem. 2011, vol. 32(no. 10), 2319–2327. [Google Scholar] [CrossRef] [PubMed]
- Gowers, R. J.; et al. MDAnalysis: A Python Package for the Rapid Analysis of Molecular Dynamics Simulations. 2016. Available online: http://mdanalysis.org.
- Hunter, J. D. Matplotlib: A 2D graphics environment. Comput. Sci. Eng. 2007, vol. 9(no. 3), 90–95. [Google Scholar] [CrossRef]
- Welcome to Python.org. Available online: https://www.python.org/ (accessed on 21 May 2026).
- Huang, C. hsien; Mason, J. T. Structure and properties of mixed-chain phospholipid assemblies. Biochim. Et. Biophys. Acta (BBA) -Rev. Biomembr. 1986, vol. 864(no. 3–4), 423–470. [Google Scholar] [CrossRef] [PubMed]
- Goto, M.; Ishida, S.; Tamai, N.; Matsuki, H.; Kaneshina, S. Chain asymmetry alters thermotropic and barotropic properties of phospholipid bilayer membranes. Chem. Phys. Lipids 2009, vol. 161(no. 2), 65–76. [Google Scholar] [CrossRef] [PubMed]
- Vermeer, L. S.; De Groot, B. L.; Réat, V.; Milon, A.; Czaplicki, J. Acyl chain order parameter profiles in phospholipid bilayers: computation from molecular dynamics simulations and comparison with 2H NMR experiments. Eur. Biophys. J. 2007, vol. 36(no. 8), 919–931. [Google Scholar] [CrossRef] [PubMed]
- Róg, T.; Girych, M.; Bunker, A. Mechanistic understanding from molecular dynamics in pharmaceutical research 2: Lipid membrane in drug design. Pharmaceuticals 2021, vol. 14(no. 10). [Google Scholar] [CrossRef] [PubMed]
- Chen, J.; Chen, L.; Wang, Y.; Wang, X.; Zeng, S. Exploring the Effects on Lipid Bilayer Induced by Noble Gases via Molecular Dynamics Simulations. Sci. Rep. 2015, 2015 5:1, vol. 5(no. 1), 17235. [Google Scholar] [CrossRef] [PubMed]
- Jaakola, V. P.; et al. The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 2008, vol. 322(no. 5905), 1211–1217. [Google Scholar] [CrossRef] [PubMed]
- Do, H. N.; Akhter, S.; Miao, Y. “Pathways and Mechanism of Caffeine Binding to Human Adenosine A2A Receptor,” Front. Mol. Biosci. 2021, vol. 8, 673170. [Google Scholar] [CrossRef]












Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).